Cold Chain Market: Huge Demands in Global Vaccine Industry

1. Reliable Cold Chain Infrastructure is Critical for the Success of the Vaccines Industry Imarc www.imarcgroup.com Global Healthcare Cold Chain Logistics Market Report and Forecast (2016-2020) Published : May 2015 Contact Us IMARC Group Email: sales@imarcgroup.com Website: www.imarcgroup.com Phone: (US)+1-631-791-1145, (IND) 91-120-415-5099 Request Sample Enquiry Buy Now Copyright © 2015 International Market Analysis Research & Consulting (IMARC). All Rights Reserved Copyright © 2015 International Market Analysis Research & Consulting (IMARC). All Rights Reserved

2. Imarc www.imarcgroup.com About IMARC Group The International Market Analysis Research and Consulting Group is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results. 2

3. Imarc www.imarcgroup.com Report Description and Highlights Reliable Cold Chain Infrastructure is Critical for the Success of the Vaccines Industry Vaccines are temperature sensitive biological products that can become less effective or even ineffective if they are exposed to light or temperatures beyond their permissible range (+2°C to +8°C). Vaccines are a cost-effective solution for numerous diseases and are currently generating savings worth billions of dollars in the healthcare system every year. The global vaccines market grew at a CAGR of nearly 10% during 2007-2014 and is expected to reach values worth US$ 55 Billion by 2020. The production of vaccines is currently concentrated within Europe, North America and a few Asian countries, its consumption, however, is diversified across the globe. Vaccines are currently being exported from a few manufacturing countries to the whole world. Since the movement of vaccines depend upon the controlled and un- compromised transfer of shipments, this is creating a huge demand for efficient cold chain logistics services in the global vaccines industry. Vaccines are temperature sensitive biological products that can become less effective or even ineffective if they are exposed to light or temperatures beyond their permissible range (+2°C to +8°C). At low temperature of 0°C or below, vaccines can experience an immediate loss of their potency followed by freezing. Vaccines may not appear frozen but can be easily damaged at very low temperatures. Similarly, when vaccines are exposed to higher temperatures, they may reduce some of their potency which is cumulative, permanent and irreversible with repeated exposures. Such failures in the storage and transportation of vaccines may result in their reduced supply, significant losses and a re-occurrence of vaccines preventable diseases. Inefficient storage and transportation may also result in the cancellation of immunization clinics, revaccination of people who have received an ineffective vaccine and a great loss of public confidence in vaccines and the healthcare systems. Thus, in order to insure that vaccines arrive at their intended destination without becoming compromised, it is essential to maintain a secure cold chain throughout their storage, handling and transportation. 3

4. Imarc www.imarcgroup.com Success of the Vaccines Industry 4

5. Imarc www.imarcgroup.com Report Description and Highlights IMARC Group’s latest report titled, “Global Healthcare Cold Chain Logistics Market Report and Forecast (2016-2020)”, which is the fourth edition of our highly acclaimed publication, provides a comprehensive insight into the logistic opportunities in the global healthcare market. The study, that has been undertaken using both desk based and qualitative primary market research, has analyzed three aspects of the global healthcare cold chain logistics market. The report has analysed the opportunities for cold chain logistics services not only in the vaccines industry but also in the clinical trial materials and biopharmaceuticals. This report also gives an insight into the market trends, market segments, regional breakup, challenges, global trade scenario and the key players in the global healthcare cold chain logistics industry. The report, which is based on both desk based research and multiple waves of primary research is a must read for anyone who plans to venture into the healthcare cold chain logistics services industry. What we have achieved in this report? Understanding the Healthcare Cold Chain Distribution Process Focus of the Analysis: • Understanding the various methods of cold chain distribution and their advantages/disadvantages • Understanding the cold chain requirements for various temperature sensitive healthcare products and the impact of temperature excursions • Understanding the key steps required in the setting and organization of an efficient cold chain distribution process • Understanding the various costs involved in cold chain transportation and comparing it with non-cold chain transportation 5

6. Imarc www.imarcgroup.com Report Description and Highlights Comprehensive Market Analysis of the Healthcare Cold Chain Logistic Services Market Focus of the analysis: • • Analyzing and evaluating the global healthcare cold chain logistic services market Analyzing and evaluating the global healthcare cold chain logistic services market by product o Biopharmaceuticals o Vaccines o Clinical trials • Analyzing and evaluating the global healthcare cold chain logistic services by segment o Transportation o Packaging o Instrumentation • Analyzing and evaluating the global healthcare cold chain logistic services market by Region o North America o Europe o Asia Pacific 6

7. Imarc www.imarcgroup.com Report Description and Highlights Comprehensive Market Analysis of Temperature Sensitive Healthcare Products: Classes Covered: Biopharmaceuticals, Vaccines and Clinical Trial Materials Focus of the Analysis in Each Class: • • • • • Drivers and challenges Historical and future sales trends Logistic requirements Impact of temperature excursions Opportunities in cold chain services Information Sources: • • • Information has been sourced from both primary and secondary sources: Primary sources include industry surveys and face to face/telephone interviews with industry experts. Secondary sources include proprietary databases and search engines. These sources include company websites and reports, books, trade journals, magazines, white papers, industry portals, government sources and access to more than 4000 paid databases. 7

8. Imarc www.imarcgroup.com Contact Us To buy the complete report or to get a free sample, please contact: IMARC Group Asia: Email: apac@imarcgroup.com Phone: +91-120-415-5099 IMARC Group North America: Email: america@imarcgroup.com Phone: +1-631-791-1145 IMARC Group Europe, Middle East & Africa: Email: ema@imarcgroup.com Phone: +44-702-409-7331 To know more please visit: http://www.imarcgroup.com/healthcare-cold-chain-logistics-market/ 8

9. Imarc www.imarcgroup.com Browse Related Reports Pharmaceutical Contract Packaging Plant Project Report: Industry Trends, Manufacturing Process, Machinery, Raw Materials, Cost and Revenue - http://www.imarcgroup.com/pharmaceutical-contract- packaging-plant Biosimilar/Follow-on Biologics Market Report & Forecast: A Focus on the US (2011-2020) - http://www.imarcgroup.com/biosimilar-market Global Biopharmaceutical Market Report (2012-2017) - http://www.imarcgroup.com/biotechnology- industry 9

10. Imarc www.imarcgroup.com © 2015 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies. 10